File Download

There are no files associated with this item.

  • Find it @ UNIST can give you direct access to the published full text of this article. (UNISTARs only)

Views & Downloads

Detailed Information

Cited time in webofscience Cited time in scopus
Metadata Downloads

Full metadata record

DC Field Value Language
dc.citation.endPage 204 -
dc.citation.number 2 -
dc.citation.startPage 192 -
dc.citation.title JOURNAL OF CONTROLLED RELEASE -
dc.citation.volume 164 -
dc.contributor.author Mehta, Geeta -
dc.contributor.author Hsiao, Amy Y. -
dc.contributor.author Ingram, Marylou -
dc.contributor.author Luker, Gary D. -
dc.contributor.author Takayama, Shuichi -
dc.date.accessioned 2023-12-22T04:36:58Z -
dc.date.available 2023-12-22T04:36:58Z -
dc.date.created 2013-06-21 -
dc.date.issued 2012-12 -
dc.description.abstract Multicellular spheroids are three dimensional in vitro microscale tissue analogs. The current article examines the suitability of spheroids as an in vitro platform for testing drug delivery systems. Spheroids model critical physiologic parameters present in vivo, including complex multicellular architecture, barriers to mass transport, and extracellular matrix deposition. Relative to two-dimensional cultures, spheroids also provide better target cells for drug testing and are appropriate in vitro models for studies of drug penetration. Key challenges associated with creation of uniformly sized spheroids, spheroids with small number of cells and co-culture spheroids are emphasized in the article. Moreover, the assay techniques required for the characterization of drug delivery and efficacy in spheroids and the challenges associated with such studies are discussed. Examples for the use of spheroids in drug delivery and testing are also emphasized. By addressing these challenges with possible solutions, multicellular spheroids are becoming an increasingly useful in vitro tool for drug screening and delivery to pathological tissues and organs -
dc.identifier.bibliographicCitation JOURNAL OF CONTROLLED RELEASE, v.164, no.2, pp.192 - 204 -
dc.identifier.doi 10.1016/j.jconrel.2012.04.045 -
dc.identifier.issn 0168-3659 -
dc.identifier.scopusid 2-s2.0-84869495994 -
dc.identifier.uri https://scholarworks.unist.ac.kr/handle/201301/3494 -
dc.identifier.url http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84869495994 -
dc.identifier.wosid 000312947500012 -
dc.language 영어 -
dc.publisher ELSEVIER SCIENCE BV -
dc.title Opportunities and challenges for use of tumor spheroids as models to test drug delivery and efficacy -
dc.type Article -
dc.relation.journalWebOfScienceCategory Chemistry, Multidisciplinary; Pharmacology & Pharmacy -
dc.relation.journalResearchArea Chemistry; Pharmacology & Pharmacy -
dc.description.journalRegisteredClass scie -
dc.description.journalRegisteredClass scopus -
dc.subject.keywordAuthor Spheroids -
dc.subject.keywordAuthor Drug delivery -
dc.subject.keywordAuthor Drug screening -
dc.subject.keywordAuthor High throughput -
dc.subject.keywordAuthor Tissue engineering -
dc.subject.keywordAuthor Imaging -
dc.subject.keywordPlus INVERTED COLLOIDAL CRYSTALS -
dc.subject.keywordPlus RAT HEPATOCYTE SPHEROIDS -
dc.subject.keywordPlus EMBRYONIC STEM-CELLS -
dc.subject.keywordPlus BREAST-CANCER CELLS -
dc.subject.keywordPlus CYTO-TOXIC DRUGS -
dc.subject.keywordPlus MULTICELLULAR TUMOR -
dc.subject.keywordPlus IN-VITRO -
dc.subject.keywordPlus CULTURE-SYSTEM -
dc.subject.keywordPlus I-131 METAIODOBENZYLGUANIDINE -
dc.subject.keywordPlus STATISTICAL PARAMETER -

qrcode

Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.